HGS inks antibody pact with 4-Antibody AG

Switzerland's 4-Antibody AG has forged a new antibody discovery pact, this time with Human Genome Sciences on two undisclosed targets. No numbers were given for the collaboration, which follows on a similar pact that 4-Antibody struck with Boehringer in early 2010. "We're delighted to announce our second collaboration with an established pharmaceutical partner," says CEO Robert Burns. "Collaborations serve an important role in validating our Retrocyte Display technology platform and we're delighted that HGS wanted to enter into this multi-target collaboration with us. This adds an additional momentum to our other ongoing partnering activities." Release

Suggested Articles

The takeover centers on a near-approval anti-CGRP antibody that could address Lundbeck’s need for near-term revenue drivers.

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.